nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Discomfort—Pentoxifylline—systemic scleroderma	0.00599	0.00599	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Betahistine—Erythema multiforme—Captopril—systemic scleroderma	0.00586	0.00586	CcSEcCtD
Betahistine—Confusional state—Pentoxifylline—systemic scleroderma	0.00586	0.00586	CcSEcCtD
Betahistine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00581	0.00581	CcSEcCtD
Betahistine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.0058	0.0058	CcSEcCtD
Betahistine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00567	0.00567	CcSEcCtD
Betahistine—Skin disorder—Pentoxifylline—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Betahistine—Angioedema—Mometasone—systemic scleroderma	0.00561	0.00561	CcSEcCtD
Betahistine—Asthma—Lisinopril—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Betahistine—Bronchospasm—Lisinopril—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Betahistine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Betahistine—Somnolence—Pentoxifylline—systemic scleroderma	0.00517	0.00517	CcSEcCtD
Betahistine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Betahistine—Erythema multiforme—Azathioprine—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Betahistine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Betahistine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Betahistine—Ill-defined disorder—Captopril—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Betahistine—Angioedema—Captopril—systemic scleroderma	0.00493	0.00493	CcSEcCtD
Betahistine—Immune system disorder—Azathioprine—systemic scleroderma	0.00489	0.00489	CcSEcCtD
Betahistine—Malaise—Captopril—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Betahistine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Betahistine—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Betahistine—Erythema multiforme—Leflunomide—systemic scleroderma	0.00483	0.00483	CcSEcCtD
Betahistine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Betahistine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00479	0.00479	CcSEcCtD
Betahistine—Urticaria—Pentoxifylline—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Betahistine—Immune system disorder—Leflunomide—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Betahistine—Discomfort—Captopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Betahistine—Dyspnoea—Mometasone—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Betahistine—Confusional state—Captopril—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Betahistine—Dyspepsia—Mometasone—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Betahistine—Anaphylactic shock—Captopril—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Betahistine—Flatulence—Leflunomide—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Betahistine—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Betahistine—Hallucination—Lisinopril—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Betahistine—Fatigue—Mometasone—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Betahistine—Tachycardia—Captopril—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Betahistine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Betahistine—Malaise—Azathioprine—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Betahistine—Flatulence—Mycophenolic acid—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Betahistine—Asthenia—Pentoxifylline—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Betahistine—Erythema multiforme—Lisinopril—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Betahistine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Betahistine—Pruritus—Pentoxifylline—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Betahistine—Angioedema—Leflunomide—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Betahistine—Malaise—Leflunomide—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Betahistine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Betahistine—Discomfort—Azathioprine—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Betahistine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Betahistine—Dyspnoea—Captopril—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Betahistine—Somnolence—Captopril—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Betahistine—Dyspepsia—Captopril—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Betahistine—Dizziness—Pentoxifylline—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Betahistine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Betahistine—Malaise—Mycophenolic acid—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Betahistine—Fatigue—Captopril—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Betahistine—Flatulence—Lisinopril—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Betahistine—Discomfort—Leflunomide—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Betahistine—Skin disorder—Azathioprine—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Betahistine—Vomiting—Pentoxifylline—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Betahistine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Betahistine—Rash—Pentoxifylline—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Betahistine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Betahistine—Headache—Pentoxifylline—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Betahistine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Betahistine—Feeling abnormal—Captopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Betahistine—Asthenia—Mometasone—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Betahistine—Discomfort—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Betahistine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Betahistine—Pruritus—Mometasone—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Betahistine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Betahistine—Tachycardia—Leflunomide—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Betahistine—Skin disorder—Leflunomide—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Betahistine—Angioedema—Lisinopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Betahistine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Betahistine—Nausea—Pentoxifylline—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Betahistine—Malaise—Lisinopril—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Betahistine—Diarrhoea—Mometasone—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Betahistine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Betahistine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Betahistine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Betahistine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Betahistine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Betahistine—Abdominal distension—Prednisone—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Betahistine—Dyspnoea—Leflunomide—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Betahistine—Discomfort—Lisinopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Betahistine—Dyspepsia—Leflunomide—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Betahistine—Vomiting—Mometasone—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Betahistine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Betahistine—Rash—Mometasone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Betahistine—Asthenia—Captopril—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Betahistine—Dermatitis—Mometasone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Betahistine—Confusional state—Lisinopril—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Betahistine—Headache—Mometasone—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Betahistine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Betahistine—Fatigue—Leflunomide—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Betahistine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Betahistine—Pruritus—Captopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Betahistine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Betahistine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Betahistine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Betahistine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Betahistine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Betahistine—Tachycardia—Lisinopril—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Betahistine—Skin disorder—Lisinopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Betahistine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Betahistine—Diarrhoea—Captopril—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Betahistine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Betahistine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Betahistine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Betahistine—Nausea—Mometasone—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Betahistine—Dizziness—Captopril—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Betahistine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Betahistine—Urticaria—Leflunomide—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Betahistine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Betahistine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Betahistine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Betahistine—Vomiting—Captopril—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Betahistine—Dyspnoea—Lisinopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Betahistine—Rash—Captopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Betahistine—Dermatitis—Captopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Betahistine—Somnolence—Lisinopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Betahistine—Headache—Captopril—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Betahistine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Betahistine—Dyspepsia—Lisinopril—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Betahistine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Betahistine—Asthma—Methotrexate—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Betahistine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Betahistine—Fatigue—Lisinopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Betahistine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Betahistine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Betahistine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Betahistine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Betahistine—Diarrhoea—Azathioprine—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Betahistine—Nausea—Captopril—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Betahistine—Asthenia—Leflunomide—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Betahistine—Hallucination—Prednisone—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Betahistine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Betahistine—Pruritus—Leflunomide—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Betahistine—Dizziness—Azathioprine—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Betahistine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Betahistine—Diarrhoea—Leflunomide—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Betahistine—Urticaria—Lisinopril—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Betahistine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Betahistine—Vomiting—Azathioprine—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Betahistine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Betahistine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Betahistine—Rash—Azathioprine—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Betahistine—Dermatitis—Azathioprine—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Betahistine—Headache—Azathioprine—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Betahistine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Betahistine—Dizziness—Leflunomide—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Betahistine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Betahistine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Betahistine—Immune system disorder—Prednisone—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Betahistine—Vomiting—Leflunomide—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Betahistine—Hypersensitivity—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Betahistine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Betahistine—Rash—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Betahistine—Dermatitis—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Betahistine—Nausea—Azathioprine—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Betahistine—Headache—Leflunomide—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Betahistine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Betahistine—Asthenia—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Betahistine—Pruritus—Lisinopril—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Betahistine—Vomiting—Mycophenolic acid—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Betahistine—Rash—Mycophenolic acid—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Betahistine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Betahistine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Betahistine—Headache—Mycophenolic acid—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Betahistine—Nausea—Leflunomide—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Betahistine—Diarrhoea—Lisinopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Betahistine—Ill-defined disorder—Prednisone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Betahistine—Angioedema—Prednisone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Betahistine—Dizziness—Lisinopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Betahistine—Nausea—Mycophenolic acid—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Betahistine—Malaise—Prednisone—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Betahistine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Betahistine—Vomiting—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Betahistine—Rash—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Betahistine—Convulsion—Prednisone—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Betahistine—Dermatitis—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Betahistine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Betahistine—Headache—Lisinopril—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Betahistine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Betahistine—Discomfort—Prednisone—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Betahistine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Betahistine—Nausea—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Betahistine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Betahistine—Nervous system disorder—Prednisone—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Betahistine—Tachycardia—Prednisone—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Betahistine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Betahistine—Skin disorder—Prednisone—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Betahistine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Betahistine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Betahistine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Betahistine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Betahistine—Malaise—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Betahistine—Convulsion—Methotrexate—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Betahistine—Dyspepsia—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Betahistine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Betahistine—Fatigue—Prednisone—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Betahistine—Discomfort—Methotrexate—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Betahistine—Confusional state—Methotrexate—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Betahistine—Feeling abnormal—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Betahistine—Urticaria—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Betahistine—Somnolence—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Betahistine—Hypersensitivity—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Betahistine—Fatigue—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Betahistine—Asthenia—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Betahistine—Pruritus—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Betahistine—Diarrhoea—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Betahistine—Urticaria—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Betahistine—Dizziness—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Betahistine—Vomiting—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Betahistine—Rash—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Betahistine—Dermatitis—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Betahistine—Headache—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Betahistine—Asthenia—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Betahistine—Nausea—Prednisone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Betahistine—Pruritus—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Betahistine—Dizziness—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Betahistine—Vomiting—Methotrexate—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Betahistine—Rash—Methotrexate—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Betahistine—Headache—Methotrexate—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Betahistine—Nausea—Methotrexate—systemic scleroderma	0.00092	0.00092	CcSEcCtD
